122 related articles for article (PubMed ID: 38661526)
1. Clinicopathologic Characteristics of a Single-institution Cohort of Ovarian Adult Granulosa Cell Tumors, With Biomarker and Therapeutic Implications Utilizing the Detection of Androgen, Estrogen, and Progesterone Hormone Receptor Expression by Immunohistochemistry.
Moh M; Puzyrenko A; Summey R; Rader JS; Herrera Cano GE; Gavina JV; Rui H; Sun Y; Hopp E
Int J Gynecol Pathol; 2024 Mar; ():. PubMed ID: 38661526
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor β: Potential target for therapy in adult granulosa cell tumors?
Ciucci A; Ferrandina G; Mascilini F; Filippetti F; Scambia G; Zannoni GF; Gallo D
Gynecol Oncol; 2018 Jul; 150(1):158-165. PubMed ID: 29786517
[TBL] [Abstract][Full Text] [Related]
3. A case series of triplet anti-hormonal therapy in androgen receptor-positive recurrent adult ovarian granulosa cell tumor.
Summey RM; Rader JS; Moh M; Bradley W; Uyar D; Bishop E; McAlarnen L; Hopp E
Gynecol Oncol Rep; 2022 Dec; 44():101118. PubMed ID: 36579182
[TBL] [Abstract][Full Text] [Related]
4. Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors.
Haltia UM; Pihlajoki M; Andersson N; Mäkinen L; Tapper J; Cervera A; Horlings HM; Turpeinen U; Anttonen M; Bützow R; Unkila-Kallio L; Carpén O; Wilson DB; Heikinheimo M; Färkkilä A
J Endocr Soc; 2020 Apr; 4(4):bvaa034. PubMed ID: 32309755
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression and prognostic significance of oestrogen receptor-alpha, oestrogen receptor-beta, and progesterone receptor in stage 1 adult-type granulosa cell tumour of the ovary.
Hutton SM; Webster LR; Nielsen S; Leung Y; Stewart CJ
Pathology; 2012 Dec; 44(7):611-6. PubMed ID: 23149378
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
[TBL] [Abstract][Full Text] [Related]
7. Expression of androgen receptor in primary breast carcinoma and its relation with clinicopathologic features, estrogen, progesterone, and her-2 receptor status.
Vellaisamy G; Tirumalae R; Inchara YK
J Cancer Res Ther; 2019; 15(5):989-993. PubMed ID: 31603099
[TBL] [Abstract][Full Text] [Related]
8. Emerging biomarkers in ovarian granulosa cell tumors.
Mills AM; Chinn Z; Rauh LA; Dusenbery AC; Whitehair RM; Saks E; Duska LR
Int J Gynecol Cancer; 2019 Mar; 29(3):560-565. PubMed ID: 30833441
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors-implications for therapeutic potential.
Färkkilä A; Zauli G; Haltia UM; Pihlajoki M; Unkila-Kallio L; Secchiero P; Heikinheimo M
Tumour Biol; 2016 Sep; 37(9):11909-11916. PubMed ID: 27067438
[TBL] [Abstract][Full Text] [Related]
10. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors.
Haltia UM; Hallamaa M; Tapper J; Hynninen J; Alfthan H; Kalra B; Ritvos O; Heikinheimo M; Unkila-Kallio L; Perheentupa A; Färkkilä A
Gynecol Oncol; 2017 Jan; 144(1):83-89. PubMed ID: 27871721
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcome of recurrence in molecularly defined adult-type ovarian granulosa cell tumors.
Bryk S; Färkkilä A; Bützow R; Leminen A; Tapper J; Heikinheimo M; Unkila-Kallio L; Riska A
Gynecol Oncol; 2016 Dec; 143(3):571-577. PubMed ID: 27729108
[TBL] [Abstract][Full Text] [Related]
12. Androgen Receptor Expression in Endometrial Stromal Sarcoma: Correlation With Clinicopathologic Features.
Roy M; Kumar S; Bhatla N; Ray MD; Kumar L; Jain D; Phulware R; Mathur SR
Int J Gynecol Pathol; 2017 Sep; 36(5):420-427. PubMed ID: 28114189
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the Androgen Receptor in Older Women with Primary Breast Cancer: Association with a Panel of Biomarkers and Breast Cancer Specific Survival.
Kalvala J; Parks RM; Abdi J; Green AR; Cheung KL
Adv Ther; 2023 Jun; 40(6):2820-2835. PubMed ID: 37118159
[TBL] [Abstract][Full Text] [Related]
15. Can adjuvant chemotherapy improve the prognosis of adult ovarian granulosa cell tumors?: A narrative review.
Zhuang Y; Zhang S; Liu Y; Yang H
Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356927
[TBL] [Abstract][Full Text] [Related]
16. Comparative immunohistochemical analysis of granulosa and sertoli components in ovarian sex cord-stromal tumors with mixed differentiation: potential implications for derivation of sertoli differentiation in ovarian tumors.
Vang R; Herrmann ME; Tavassoli FA
Int J Gynecol Pathol; 2004 Apr; 23(2):151-61. PubMed ID: 15084844
[TBL] [Abstract][Full Text] [Related]
17. Expression of androgen receptor in inflammatory breast cancer and its clinical relevance.
Gong Y; Wei W; Wu Y; Ueno NT; Huo L
Cancer; 2014 Jun; 120(12):1775-9. PubMed ID: 24634055
[TBL] [Abstract][Full Text] [Related]
18. Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness.
Refaat B; Aslam A; Idris S; Almalki AH; Alkhaldi MY; Asiri HA; Almaimani RA; Mujalli A; Minshawi F; Alamri SA; AlHussain MI; Baltow BA; Alqasmi MH; Basfar GT; Alosaimi OM; Muhayya IA
Front Endocrinol (Lausanne); 2023; 14():1187259. PubMed ID: 37206439
[TBL] [Abstract][Full Text] [Related]
19. Parity, menopausal hormone therapy, and risk of ovarian granulosa cell tumor - A population-based case-control study.
Bryk S; Katuwal S; Haltia UM; Tapper J; Tapanainen JS; Pukkala E
Gynecol Oncol; 2021 Dec; 163(3):593-597. PubMed ID: 34598830
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation.
Niemeier LA; Dabbs DJ; Beriwal S; Striebel JM; Bhargava R
Mod Pathol; 2010 Feb; 23(2):205-12. PubMed ID: 19898421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
